☆ 4.8 Article

Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Jay M. Lee et al.

Summary: New adjuvant immunotherapy using immune checkpoint inhibitors (ICIs) shows potential advantages in treating resectable NSCLC, including earlier treatment of micrometastatic disease, broad activation of immune response, and guidance for adjuvant therapy.

ANNALS OF THORACIC SURGERY (2022)

Add to Collection

Article Immunology

Case Report: Immune Checkpoint Inhibitors Successfully Controlled Asymptomatic Brain Metastasis in Esophageal Squamous Cell Carcinoma

Linlin Xiao et al.

Summary: This article reports a rare case of an ESCC patient whose brain metastatic lesion completely disappeared after receiving ICIs treatment, providing supporting data for the use of ICIs as an option for treating brain metastases in ESCC patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial

Xiaotao Huang et al.

Summary: This study investigated the safety and efficacy of neoadjuvant toripalimab and GP treatment in patients with resectable locally advanced HNSCC. The results showed that this treatment regimen is feasible and achieves promising pCR and MPR rates.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

The structure of blood-tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases

Ling-Yun Ye et al.

Summary: This study found that brain metastases of lung cancer have increased BTB permeability, abnormal structure, and differ from normal brain tissue. Gemcitabine showed the highest distribution in brain metastases among the commonly used chemotherapy drugs, and the permeability of chemotherapeutic agents is related to their molecular weight and liposolubility.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Letter Oncology

Necrosis Is Not the Main Part of Immune-Related Pathologic Response to Neoadjuvant Immunotherapy in Squamous Cell Lung Cancer

Lin Li et al.

JOURNAL OF THORACIC ONCOLOGY (2021)

Add to Collection

Review Cell Biology

Treatment of Radiation-Induced Brain Necrosis

Xiaojing Yang et al.

Summary: Radiation-induced brain necrosis is a serious complication of radiotherapy for intracranial tumors, previously considered irreversible. Advances in understanding the pathogenesis and treatment options, such as the use of drugs like bevacizumab, have shown promising results in some cases of brain necrosis.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Review Immunology

Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application

Gang Xiao et al.

Summary: Brain metastases are common in NSCLC patients and immune checkpoint inhibitors (ICIs) have become a routine treatment for these patients. Various ICIs have been approved for the first-line treatment of metastatic NSCLC, but the use of PD-L1, tumor infiltrating lymphocytes, and tumor mutation burden as predictive biomarkers for ICIs in NSCLC patients with BM remains controversial with insufficient clinical data.

IMMUNOTHERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

S. S. Ramalingam et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Oncology

PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice

Inaki Eguren-Santamaria et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition

Emanuela Pasciuto et al.

CELL (2020)

Add to Collection

Review Oncology

Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review

Mark T. J. van Bussel et al.

BMC CANCER (2019)

Add to Collection

Review Oncology

Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities

Faisal S. Ali et al.

CURRENT ONCOLOGY REPORTS (2019)

Add to Collection

Review Oncology

Novel patterns of response under immunotherapy

E. Borcoman et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Review Oncology

Management of Brain Metastases in Non-Small-Cell Lung Cancer

Vinicius Ernani et al.

JOURNAL OF ONCOLOGY PRACTICE (2019)

Add to Collection

Article Oncology

Tumor Mutational Burden Is Site Specific in Non-Small-Cell Lung Cancer and Is Highest in Lung Adenocarcinoma Brain Metastases

Matthew K. Stein et al.

JCO PRECISION ONCOLOGY (2019)

Add to Collection

Article Oncology

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

T. R. Cottrell et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

L. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking

David Taggart et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer

L. Paz-Ares et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Roberto Ferrara et al.

JAMA ONCOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Immune Regulation of Antibody Access to Neuronal Tissues

Akiko Iwasaki

TRENDS IN MOLECULAR MEDICINE (2017)

Add to Collection

Review Immunology

The movers and shapers in immune privilege of the CNS

Britta Engelhardt et al.

NATURE IMMUNOLOGY (2017)

Add to Collection

Article Oncology

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

A. S. Mansfield et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

Francesco Cicone et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Add to Collection

Review Oncology

Tissue concentration of systemically administered antineoplastic agents in human brain tumors

Marshall W. Pitz et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.